These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9950251

  • 21. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis.
    Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC.
    Oral Oncol; 2003 Jun; 39(4):367-72. PubMed ID: 12676256
    [Abstract] [Full Text] [Related]

  • 22. Elevation of Twist expression by arecoline contributes to the pathogenesis of oral submucous fibrosis.
    Lee YH, Yang LC, Hu FW, Peng CY, Yu CH, Yu CC.
    J Formos Med Assoc; 2016 May; 115(5):311-7. PubMed ID: 26088962
    [Abstract] [Full Text] [Related]

  • 23. Increased expression of carbonic anhydrase IX in oral submucous fibrosis and oral squamous cell carcinoma.
    Yang JS, Chen MK, Yang SF, Chang YC, Su SC, Chiou HL, Chien MH, Lin CW.
    Clin Chem Lab Med; 2014 Sep; 52(9):1367-77. PubMed ID: 24695043
    [Abstract] [Full Text] [Related]

  • 24. Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis.
    Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS.
    Oral Oncol; 2002 Feb; 38(2):195-200. PubMed ID: 11854068
    [Abstract] [Full Text] [Related]

  • 25. The up-regulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis.
    Tsai CH, Chou MY, Chang YC.
    J Oral Pathol Med; 2003 Mar; 32(3):146-53. PubMed ID: 12581384
    [Abstract] [Full Text] [Related]

  • 26. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis.
    Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK.
    Oral Oncol; 2002 Jul; 38(5):425-30. PubMed ID: 12110335
    [Abstract] [Full Text] [Related]

  • 27. Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels.
    Tsai CH, Yang SF, Chen YJ, Chu SC, Hsieh YS, Chang YC.
    Oral Dis; 2004 Nov; 10(6):360-4. PubMed ID: 15533212
    [Abstract] [Full Text] [Related]

  • 28. Identification of the pattern of copper as an etiological factor in oral submucous fibrosis: a cytological study.
    Sharma A, Sahni P, Nayak MT, Singhvi A, Kumar R.
    J Exp Ther Oncol; 2014 Nov; 10(4):317-23. PubMed ID: 25509987
    [Abstract] [Full Text] [Related]

  • 29. Pathogenesis of oral submucous fibrosis.
    Khan S, Chatra L, Prashanth SK, Veena KM, Rao PK.
    J Cancer Res Ther; 2012 Nov; 8(2):199-203. PubMed ID: 22842361
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
    Hsieh YP, Wu KJ, Chen HM, Deng YT.
    J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
    [Abstract] [Full Text] [Related]

  • 32. Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro.
    Chang YC, Tai KW, Cheng MH, Chou LS, Chou MY.
    J Oral Pathol Med; 1998 Feb; 27(2):68-71. PubMed ID: 9526732
    [Abstract] [Full Text] [Related]

  • 33. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
    Yu CC, Liao YW, Yu CH, Chang YC.
    J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
    [Abstract] [Full Text] [Related]

  • 34. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
    Lee SS, Chen YJ, Tsai CH, Huang FM, Chang YC.
    Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
    [Abstract] [Full Text] [Related]

  • 35. An in-vitro comparison of human fibroblasts from normal and oral submucous fibrosis tissue.
    Meghji S, Scutt A, Harvey W, Canniff JP.
    Arch Oral Biol; 1987 Jun; 32(3):213-5. PubMed ID: 3478024
    [Abstract] [Full Text] [Related]

  • 36. Oral submucous fibrosis. The South African experience.
    VanWyk CW.
    Indian J Dent Res; 1997 Jun; 8(2):39-45. PubMed ID: 9495135
    [Abstract] [Full Text] [Related]

  • 37. Arecoline-induced myofibroblast transdifferentiation from human buccal mucosal fibroblasts is mediated by ZEB1.
    Chang YC, Tsai CH, Lai YL, Yu CC, Chi WY, Li JJ, Chang WW.
    J Cell Mol Med; 2014 Apr; 18(4):698-708. PubMed ID: 24400868
    [Abstract] [Full Text] [Related]

  • 38. Areca nut extract and arecoline induced the cell cycle arrest but not apoptosis of cultured oral KB epithelial cells: association of glutathione, reactive oxygen species and mitochondrial membrane potential.
    Chang MC, Ho YS, Lee PH, Chan CP, Lee JJ, Hahn LJ, Wang YJ, Jeng JH.
    Carcinogenesis; 2001 Sep; 22(9):1527-35. PubMed ID: 11532876
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of HIF1A-AS1 impedes the arecoline-induced migration activity of human oral mucosal fibroblasts.
    Wang YK, Liu CM, Lin T, Fang CY, Yu CC, Yu CH.
    J Formos Med Assoc; 2020 Apr; 119(4):879-883. PubMed ID: 31959495
    [Abstract] [Full Text] [Related]

  • 40. miR-200c inhibits the arecoline-associated myofibroblastic transdifferentiation in buccal mucosal fibroblasts.
    Lu MY, Yu CC, Chen PY, Hsieh PL, Peng CY, Liao YW, Yu CH, Lin KH.
    J Formos Med Assoc; 2018 Sep; 117(9):791-797. PubMed ID: 29958727
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.